TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)
Clinical trial NCT07355257 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07355257
- Sponsor
- Zhongming Qiu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2026-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.